טוען...
Versatile nano-delivery platform to maximize siRNA combination therapy
The unsatisfactory outcomes of typical multiple cytotoxic chemotherapeutic combination therapies used to treat patients have fostered a need for new unconventional combinations of therapeutic agents. Among the candidates, siRNA has been widely discussed and tested. However, the right time right plac...
שמור ב:
| הוצא לאור ב: | Macromol Biosci |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5310967/ https://ncbi.nlm.nih.gov/pubmed/27654639 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mabi.201600294 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|